Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumer Health Sector Holds Private Equity Investors' Attention

Executive Summary

"It's amazing with this consumer empowerment how fast that market is growing," biopharma industry veteran Fred Hassan remarks. "Coming up with good products, scientifically validated, supported by doctors and approaching consumers with proper claims, it's a huge opportunity."

Advertisement

Related Content

J&J Divests OTC Anti-Dandruff Product To Separate Buyers Across 3 Regions
Glaxo Opts For Solo Navigation To Boost Control In Consumer Health Market
GSK And Reckitt Opting Out Of Pfizer's Consumer Business Sale Speaks Volumes
Potential Buyers Assess Available OTC Assets From Disparate Views
Swanson Health Sale Could Lead Private Equity Spike In Supplement Space
Bayer Lands Merck Consumer As Springboard to Lead Global OTC Industry
In Brief: Herbalife And FTC, Reckit And K-Y, DSM In CMO JV

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122784

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel